Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediates. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Discover scalable chiral indolinopyrrole synthesis with 99% ee and 90%+ yield. Ideal for oncology drug development. Reduce costs and supply chain risks.
Discover scalable 2,6-dibromo-4-methylpyridine production with 68.5% yield and 99.5% purity. Eliminate column chromatography and reduce costs for pharmaceutical intermediates.
Discover a scalable Pd-catalyzed route for trifluoromethyl-chromone quinolines with 90%+ yields. Eliminate expensive pre-activation and harsh conditions. Reduce supply chain risks for your API synthesis.
Solve complex N-acyl indole synthesis challenges with high-yield, one-step palladium-catalyzed method. Reduce costs and scale-up risks for API production.
Discover how advanced cuprous bromide activation and palladium-catalyzed hydrogenation reduce solid waste by 90% while achieving 99.8% purity and 72% yield for AZD9291 production.
Solve axial chiral synthesis challenges with high-yield, mild-condition process. Reduce R&D costs and supply chain risks for asymmetric catalysts.
Eliminate CO gas handling risks and reduce production costs with this scalable multi-component synthesis for high-purity pharmaceutical intermediates.
Eliminate anhydrous/oxygen-free requirements in 5-trifluoromethyl triazole synthesis. Our CDMO expertise ensures high-yield, scalable production for drug intermediates.
Solve 4-aryl-NH-1,2,3-triazole synthesis challenges with this metal-free, one-pot method. Achieve 40-75% yields using stable aldehyde bisulfite adducts. Reduce production costs and supply chain risks for pharmaceutical intermediates.
Discover a cost-effective, metal-free synthesis method for 3,4,5-trisubstituted 1,2,4-triazoles. Eliminate anhydrous conditions and heavy metal catalysts to reduce production costs and supply chain risks.
High-yield, high-ee synthesis of non-natural amino acids with water as proton source. Reduce production costs and supply chain risks for API manufacturing.
Solve supply chain risks in chiral synthesis with this novel protonic acid catalyst. Achieve 98% ee and 96% yield in ruthenium-catalyzed reactions. Contact us for custom synthesis.
Discover copper-catalyzed indole synthesis with 74-90% yields, nitrogen protection, and 110°C mild conditions. Reduce R&D costs and supply chain risks for pharmaceutical intermediates.
Discover how Rh(III)-catalyzed tandem synthesis of 6-amino-5-acyl benzo[a]carbazole reduces production costs and improves yield for pharmaceutical intermediates.
Discover a novel palladium-catalyzed method for quinoline-4(1H)-ketone synthesis with high yield, broad substrate tolerance, and simplified post-treatment. Reduce production costs and supply chain risks for pharmaceutical intermediates.
Discover a cost-effective, palladium-free synthesis of Vismodegib with 99% purity. Eliminate anhydrous/oxygen-free requirements and reduce supply chain risks for your oncology projects.
Discover a cost-effective, high-yield method for indole ketone thioesters using sulfonyl chloride as sulfur source. Eliminate catalyst poisoning risks and streamline your API synthesis.
Solve high-cost, low-yield issues in tegrazan intermediate production. New route achieves ≥99% purity with simplified steps and 100kgs+ scale capability.
Solve supply chain risks with metal-free 5-trifluoromethyl triazole synthesis. 80%+ yields, no azides, scalable to 100MT. Contact for custom synthesis.
Reduce supply chain risks with metal-free deracemization process. 90%+ yield, 95% ee, and scalable production for chiral alcohol intermediates.